Running a pharmacy means functioning in a reality of continuous regulatory oversight. Unlike many other sectors of the economy, the scope of interest of control authorities is not limited solely to the legality of conducting business activity, but encompasses areas such as public health safety, the trade in medicinal products, food, medical devices, consumer protection, reimbursement, and personal data protection. What are Sanepid inspectors looking for, and who bears responsibility for the product?<\/p>\n\n\n\n
Sanepid Inspection \u2013 What Inspectors Are Actually Looking For<\/strong><\/p>\n\n\n\n In the public consciousness, inspections by the State Sanitary Inspection are still associated primarily with evaluating the cleanliness of the premises. This is, however, a far-reaching simplification.<\/p>\n\n\n\n The primary task of the State Sanitary Inspection remains the protection of public health by exercising supervision over hygienic and health conditions, as well as food safety. In the case of pharmacies, this means the possibility of inspecting both premise conditions and products classified as food, in particular dietary supplements.<\/p>\n\n\n\n Inspectors possess broad powers, including access to all pharmacy premises, requesting documentation to be made available, taking samples for laboratory testing, requesting oral or written explanations, and conducting inspections of equipment and products.<\/p>\n\n\n\n The subject of an inspection usually includes product storage conditions, temperature and humidity monitoring, HACCP documentation, waste management, product traceability, quality documentation, and the labeling of dietary supplements.<\/p>\n\n\n\n At the same time, inspections are increasingly going beyond classic sanitary issues and encompassing how products are presented to consumers.<\/p>\n\n\n\n Responsibility Does Not End with the Manufacturer<\/strong><\/p>\n\n\n\n It is a misconception that responsibility for a product’s compliance with regulations rests solely on the manufacturer.<\/p>\n\n\n\n In practice, the pharmacy constitutes the final link in the distribution chain, and it is precisely its activity that remains directly visible to the consumer and control authorities.<\/p>\n\n\n\n Placing a product with improper labeling on the market, using materials containing prohibited claims, or failing to react to information about product non-compliances can result in liability regardless of the supplier’s assurances.<\/p>\n\n\n\n Therefore, the qualification of business partners, the analysis of marketing materials, and appropriate contractual safeguards regarding responsibility for product compliance and the communications provided become particularly important.<\/p>\n\n\n\n In the current form of pharmacy and pharmacy sales inspections, the most serious risks do not stem from a misunderstanding of the regulations, but from operational errors. An improperly displayed product, an unverified flyer, a message duplicated from the manufacturer, or a seemingly innocent post by an influencer can become the beginning of proceedings conducted by Sanepid, followed by interest from other supervisory bodies.<\/p>\n\n\n\n For this reason, regulatory compliance should be viewed not as a formal obligation, but as an element of business risk management in the pharmaceutical and food sectors. In practice, it is daily operational decisions, rather than knowledge of the regulations themselves, that determine the outcome of an inspection.<\/p>\n\n\n\n To avoid unnecessary stress, it is worth always being prepared for a potential inspection. To this end, it is recommended to implement standardized rules of conduct during an inspection, as well as checklists that can help ensure “nothing is overlooked” during the daily operation of the pharmacy.<\/p>\n\n\n\n An inspection is a part of functioning for every pharmacy and does not need to be treated as an extraordinary situation. However, if doubts arise regarding the scope of inspection activities, the manner of providing explanations, or the assessment of identified non-compliances, it can be helpful to use the support of a law firm specializing in the pharmaceutical industry. This allows the entire process to be handled in an orderly and calm manner, focusing on running the business while ensuring appropriate legal support at every stage of the inspection.<\/p>\n\n\n\n What to Do Next, Then?<\/strong><\/p>\n\n\n\n An inspection is not always announced and does not always start with an inspector’s visit to the pharmacy. A single social media publication can serve as an impulse for an authority to take action.<\/p>\n\n\n\n Sanitary inspection authorities are increasingly interested in marketing activities concerning dietary supplements, rather than exclusively the facility’s sanitary conditions. Health claims and advertising will be covered in the next article in the series. The authorities’ attention is particularly drawn to the way products positioned on the borderline between a dietary supplement and a medicinal product are presented. Sometimes, even seemingly neutral informational or promotional materials can become the basis for initiating administrative proceedings. In these realities, compliance ceases to be merely a legal requirement and becomes an essential tool for risk management and protecting the pharmacy’s operations.<\/p>\n\n\n\n If you have questions related to inspections in the pharmacy market, please feel free to contact us: ajlaw.pl juchanska@ajlaw.pl office@ajlaw.pl<\/p>\n","protected":false},"excerpt":{"rendered":" Running a pharmacy means functioning in a reality of continuous regulatory oversight. Unlike many other sectors of the economy, the scope of interest of control authorities is not limited solely to the legality of conducting business activity, but encompasses areas such as public health safety, the trade in medicinal products, food, medical devices, consumer protection, reimbursement, and personal data protection. What are Sanepid inspectors looking for, and who bears responsibility for the product?<\/p>\n","protected":false},"author":5,"featured_media":1641,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[384,216,238,385],"class_list":["post-1652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bez-kategorii","tag-inspectors","tag-law","tag-pharmacy","tag-resposibility"],"acf":[],"_links":{"self":[{"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/posts\/1652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/comments?post=1652"}],"version-history":[{"count":1,"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/posts\/1652\/revisions"}],"predecessor-version":[{"id":1653,"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/posts\/1652\/revisions\/1653"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/media\/1641"}],"wp:attachment":[{"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/media?parent=1652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/categories?post=1652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ajlaw.pl\/en\/wp-json\/wp\/v2\/tags?post=1652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}